Eli Lilly and Company has announced a definitive agreement to acquire clinical-stage biopharmaceutical firm AtaiBeckley in a transaction valued at up to $3.8 billion. The acquisition aims to significa...

The U.S. Food and Drug Administration has granted approval to Otsuka Pharmaceutical for SIMTRIYO (centanafadine), marking the first regulatory clearance for a norepinephrine, dopamine, serotonin reupt...

Key Regulatory ProposalsSanofi has officially terminated its clinical development program for amlitelimab, an OX40-ligand targeting monoclonal antibody previously intended for the treatment of moderat...

On July 16, 2026, the Centers for Medicare & Medicaid Services (CMS) issued a new draft guidance that fills in critical operational details for the Inflation Reduction Act’s drug price negotiation pro...

The Centers for Medicare & Medicaid Services (CMS) has unveiled a comprehensive, three-pillar strategy aimed at fundamentally restructuring Original Medicare (OM) by transitioning away from traditiona...

Merck has secured FDA approval for LIPFENDRA (enlicitide) 20 mg tablets, establishing the first oral PCSK9 inhibitor available for the management of hypercholesterolemia. Approved as an adjunct to die...

Sinabi ng Pfizer Canada na naglagay ito ng pansamantalang limitasyon sa mga order ng isa sa kanilang mga COVID na bakuna sa mga parmasya sa komunidad.

The European Commission has issued marketing authorization for once-daily oral semaglutide 25 mg tablets, marketed under the Wegovy brand, for the management of obesity and weight-associated comorbidi...

The U.S. Food and Drug Administration (FDA) has approved Celcuity’s REVTORPYK (gedatolisib) for the treatment of HR+/HER2- metastatic breast cancer patients who do not possess a PIK3CA mutation. As th...

The Centers for Medicare & Medicaid Services (CMS) has introduced a broad regulatory proposal aimed at restructuring Medicare physician payments and accelerating the transition toward value-based care...